Medtronic (MDT) Stock Price, News & Analysis

Company Overview

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions). The company also supplies a range of hospital products and services that support perioperative and procedural care.

Medtronic operates on a global scale, serving customers in more than 150 countries through a combination of direct sales, distribution partners and clinical service programs. Its customers include hospitals, ambulatory surgery centers and specialty clinics, and the company emphasizes clinical collaboration, training and post-market support as part of its commercial approach. Medtronic maintains a significant research-and-development focus to advance new therapies and meet evolving regulatory and clinical requirements.

The company’s executive leadership team is responsible for steering Medtronic’s strategy around innovation, reimbursement and market access; Geoffrey S. Martha has served as chief executive in recent years. Medtronic’s business model centers on developing technology-enabled therapies, expanding clinical evidence, and scaling commercial capabilities to address chronic and acute conditions across diverse geographies.

Key Stats

• Today's Range: $78.21 to $79.25
• 50-Day Range: $74.56 to $88.65
• 52-Week Range: $74.40 to $106.33
• Volume: 7.05 million shs
• Average Volume: 10.01 million shs
• Market Capitalization: $100.99 billion
• P/E Ratio: 21.91
• Dividend Yield: 3.61%
• Price Target: $106.45
• Consensus Rating: Moderate Buy

Medtronic Stock Analysis - MarketRank™

Medtronic scored higher than 99% of companies evaluated by MarketBeat, and ranked 4th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Medtronic has received a consensus rating of Moderate Buy. The company's average rating score is 2.58, and is based on no strong buy ratings, 15 buy ratings, 11 hold ratings, and no sell ratings.

Upside Potential

Medtronic has a consensus price target of $106.45, representing about 35.3% upside from its current price of $78.66.

Amount of Analyst Coverage

Medtronic has been the subject of 16 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 9.55%

Earnings Growth

Earnings for Medtronic are expected to grow by 9.55% in the coming year, from $5.55 to $6.08 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Medtronic is 21.91, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.02.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medtronic is 21.91, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.06.

Price to Earnings Growth Ratio

Medtronic has a PEG Ratio of 1.87. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Medtronic has a P/B Ratio of 2.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.14% of the float of Medtronic has been sold short.

Short Interest Ratio / Days to Cover

Medtronic has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medtronic has recently decreased by 5.51%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Leadership

Medtronic is a leading dividend payer. It pays a dividend yield of 3.61%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Medtronic has been increasing its dividend for 49 years.

Dividend Coverage

The dividend payout ratio of Medtronic is 79.11%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Medtronic will have a dividend payout ratio of 46.71% next year. This indicates that Medtronic will be able to sustain or increase its dividend.

News and Social Media

• Score: 4.3 / 5
• News Sentiment: 0.90

News Sentiment

Medtronic has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 33 news articles for Medtronic this week, compared to 12 articles on an average week.

Search Interest

94 people have searched for MDT on MarketBeat in the last 30 days. This is an increase of 32% compared to the previous 30 days.

MarketBeat Follows

37 people have added Medtronic to their MarketBeat watchlist in the last 30 days. This is an increase of 131% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Medtronic insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.26% of the stock of Medtronic is held by insiders.

Percentage Held by Institutions

82.06% of the stock of Medtronic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 2/17/2026
• Record date for 4/17 Dividend: 3/27/2026
• Ex-Dividend for 4/17 Dividend: 3/27/2026
• Dividend Payable: 4/17/2026
• Today: 5/24/2026
• Next Earnings (Estimated): 6/03/2026
• Fiscal Year End: 4/30/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:MDT
• CIK: 1613103
• Web: www.medtronic.com
• Phone: (531) 438-1700
• Fax: 763-514-4879
• Employees: 95,000
• Year Founded: 1949

Price Target and Rating

• Average Price Target for Medtronic: $106.45
• High Price Target: $120.00
• Low Price Target: $84.00
• Potential Upside/Downside: +35.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.58
• Research Coverage: 26 Analysts

Profitability

• EPS (Trailing Twelve Months): $3.59
• Trailing P/E Ratio: 21.91
• Forward P/E Ratio: 14.17
• P/E Growth: 1.87
• Net Income: $4.66 billion
• Net Margins: 13.00%
• Pretax Margin: 15.68%
• Return on Equity: 14.82%
• Return on Assets: 7.88%

Debt

• Debt-to-Equity Ratio: 0.57
• Current Ratio: 2.54
• Quick Ratio: 1.87

Sales & Book Value

• Annual Sales: $33.54 billion
• Price / Sales: 3.01
• Cash Flow: $7.76 per share
• Price / Cash Flow: 10.14
• Book Value: $37.62 per share
• Price / Book: 2.09

Miscellaneous

• Outstanding Shares: 1,283,890,000
• Free Float: 1,280,547,000
• Market Cap: $100.99 billion
• Optionable: Optionable
• Beta: 0.62